Radiology, Vol 195, 489-496, Copyright © 1995 by Radiological Society of North America

ARTICLES

Clinical results with Resovist: a phase 2 clinical trial

P Reimer, EJ Rummeny, HE Daldrup, T Balzer, B Tombach, T Berns and PE Peters
Institute of Clinical Radiology, Westfalian Wilhelms-University, Munster, Germany.

PURPOSE: To investigate the superparamagnetic iron oxide (Resovist) designed for contrast material-enhanced magnetic resonance imaging of the liver. MATERIALS AND METHODS: A phase 2 trial was performed in 33 patients with no more than five known focal solid liver lesions. Resovist was administered intravenously at doses of 4, 8, and 16 mumol of iron per kilogram of body weight. Postcontrast 1.0-T imaging was started 30 minutes after injection. RESULTS: Resovist significantly (P < or = .05) decreased liver signal intensity and increased lesion-to- liver contrast-to-noise ratio (C/N) and the number of detectable liver lesions: fast spin-echo (SE) (echo time, 90 msec) precontrast C/N, 11.7 +/- 7.9 [standard deviation]; postcontrast [8-mumol Fe/Kg] C/N, 29.2 +/- 14.2). The dose of 8 mumol Fe/kg was sufficient for the detection of focal liver lesions, and T2-weighted fast SE with an echo time of 90 msec was the overall best pulse sequence. CONCLUSION: Resovist is a safe contrast agent, and a dose of 8 mumol Fe/kg is sufficient to enhance detection of focal liver lesions at T2-weighted fast SE MR imaging.

This article has been cited by other articles:

				A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging Radiology, November 1, 2005; 237(2): 520 - 528. [Abstract] [Full Text] [PDF]

				P. Reimer, C. Bremer, T. Allkemper, M. Engelhardt, M. Mahler, W. Ebert, and B. Tombach Myocardial Perfusion and MR Angiography of Chest with SH U 555 C: Results of Placebo-controlled Clinical Phase I Study Radiology, May 1, 2004; 231(2): 474 - 481. [Abstract] [Full Text] [PDF]

				M. Matsuo, M. Kanematsu, K. Itoh, K. Ito, Y. Maetani, H. Kondo, N. Kako, N. Matsunaga, H. Hoshi, and J. Shiraishi Detection of Malignant Hepatic Tumors: Comparison of Gadolinium-and Ferumoxide-Enhanced MR Imaging Am. J. Roentgenol., September 1, 2001; 177(3): 637 - 643. [Abstract] [Full Text] [PDF]

				R. C. Semelka and T. K. G. Helmberger Contrast Agents for MR Imaging of the Liver Radiology, January 1, 2001; 218(1): 27 - 38. [Abstract] [Full Text]

				P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis Radiology, October 1, 2000; 217(1): 152 - 158. [Abstract] [Full Text]

				H. Kondo, M. Kanematsu, H. Hoshi, T. Murakami, T. Kim, M. Hori, M. Matsuo, and H. Nakamura Preoperative Detection of Malignant Hepatic Tumors: Comparison of Combined Methods of MR Imaging with Combined Methods of CT Am. J. Roentgenol., April 1, 2000; 174(4): 947 - 954. [Abstract] [Full Text] [PDF]

				J. Ward, F. Chen, J. A. Guthrie, D. Wilson, J. P. A. Lodge, J. I. Wyatt, and P. J. Robinson Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis1 Radiology, January 1, 2000; 214(1): 159 - 166. [Abstract] [Full Text]

				J. Ward, K. S. Naik, J. A. Guthrie, D. Wilson, and P. J. Robinson Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative–Free Response Receiver Operating Characteristic Analysis Radiology, February 1, 1999; 210(2): 459 - 466. [Abstract] [Full Text]

				T. Allkemper, C. Bremer, L. Matuszewski, W. Ebert, and P. Reimer Contrast-enhanced Blood-Pool MR Angiography with Optimized Iron Oxides: Effect of Size and Dose on Vascular Contrast Enhancement in Rabbits Radiology, May 1, 2002; 223(2): 432 - 438. [Abstract] [Full Text] [PDF]